New ultrasound technique could spare liver patients from costly scans and needles
NCT ID NCT00243633
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a special ultrasound with contrast dye (CEUS) can more accurately identify liver lesions than standard ultrasound or other imaging methods like CT and MRI. Researchers enrolled 878 participants with liver lesions found on standard ultrasound. The goal was to see if CEUS could provide a reliable diagnosis without needing invasive biopsies, potentially saving costs and discomfort.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Contrast-enhanced ultrasound (CEUS) imaging
- What this could lead to
- If successful, CEUS could become a standard, non-invasive way to accurately diagnose liver lesions, reducing the need for more expensive or invasive tests like CT, MRI, or biopsy.
- What could go wrong
- This is a completed study, so results are already known. The main risk is that CEUS may not be accurate enough for all types of liver lesions, and it cannot be used in patients with certain heart conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL LIVER LESIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU d'ANGERS
Angers, 49033, France
-
Hospices Civils de Lyon
Lyon, 69003, France
-
Hôpital Beaujon, Assistance Publique Hôpitaux de Paris
Clichy, 92118, France
-
Hôpital Bretonneau, CHRU Tours
Tours, 37044, France
-
Hôpital La Milétrie, CHRU Poitiers
Poitiers, 86000, France
-
Hôpital Necker, Assistance Publique Hôpitaux de Paris
Paris, 75743, France
-
Hôpital Nord, CHRU Saint-Etienne
Saint-Etienne, 42055, France
-
Hôpital Paul Brousse, Assistance Publique Hôpitaux de Paris
Villejuif, 94804, France
-
Hôpital Pitié Salpétrière, Assistance Publique Hôpitaux de Paris
Paris, 75651, France
-
Hôpital Robert Debré, CHRU Reims
Reims, 51092, France
-
Hôpital Saint-André, CHRU Bordeaux
Bordeaux, 33075, France
-
Hôpital Saint-Eloi, CHRU Montpellier
Montpellier, 34295, France
-
Hôpital Saint-Jacques, CHRU Besancon
Besançon, 25000, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Service de Radiologie, Hôpital d'Enfants de Brabois
Vandœuvre-lès-Nancy, 54511, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood thinner may stop early cirrhosis from turning deadly — a major trial puts it to the test
- Can an epidural pump beat IV painkillers after liver surgery?
- Could a two-vein embolization trick turn inoperable liver tumors into operable ones?
- Stick-On ultrasound patch could spot liver damage without a specialist
- Could MRI replace CT for sharper cancer radiation planning?
- Blood test and AI could spot liver cancer early, saving lives